Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

Cancer is one of the leading causes of death in the industrialized world and represents a tremendous social and economic burden. As conventional therapies fail to provide a sustainable cure for most cancer patients, the emerging unique immune therapeutic approach of bacteria-mediated tumor therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Felgner, Sebastian, Kocijancic, Dino, Frahm, Michael, Heise, Ulrike, Rohde, Manfred, Zimmermann, Kurt, Falk, Christine, Erhardt, Marc, Weiss, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749626/
https://www.ncbi.nlm.nih.gov/pubmed/29308303
http://dx.doi.org/10.1080/2162402X.2017.1382791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749626/
https://www.ncbi.nlm.nih.gov/pubmed/29308303
http://dx.doi.org/10.1080/2162402X.2017.1382791

Ejemplares similares